These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 20890217
1. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency. Brunt EM, Blomenkamp K, Ahmed M, Ali F, Marcus N, Teckman J. J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217 [Abstract] [Full Text] [Related]
5. Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency. Marcus NY, Blomenkamp K, Ahmad M, Teckman JH. Exp Biol Med (Maywood); 2012 Oct; 237(10):1163-72. PubMed ID: 23104507 [Abstract] [Full Text] [Related]
6. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort. Clark VC, Marek G, Liu C, Collinsworth A, Shuster J, Kurtz T, Nolte J, Brantly M. J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687 [Abstract] [Full Text] [Related]
7. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis. Mencin A, Seki E, Osawa Y, Kodama Y, De Minicis S, Knowles M, Brenner DA. Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872 [Abstract] [Full Text] [Related]
8. Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions. Teckman JH, Mangalat N. Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):261-8. PubMed ID: 25066184 [Abstract] [Full Text] [Related]
9. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model. Lindblad D, Blomenkamp K, Teckman J. Hepatology; 2007 Oct; 46(4):1228-35. PubMed ID: 17886264 [Abstract] [Full Text] [Related]
10. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation. Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, Dolman GE, Reichert MC, Schneider CV, Woditsch V, Voss J, Lindhauer C, Fromme M, Spivak I, Guldiken N, Zhou B, Arslanow A, Schaefer B, Zoller H, Aigner E, Reiberger T, Wetzel M, Siegmund B, Simões C, Gaspar R, Maia L, Costa D, Bento-Miranda M, van Helden J, Yagmur E, Bzdok D, Stolk J, Gleiber W, Knipel V, Windisch W, Mahadeva R, Bals R, Koczulla R, Barrecheguren M, Miravitlles M, Janciauskiene S, Stickel F, Lammert F, Liberal R, Genesca J, Griffiths WJ, Trauner M, Krag A, Trautwein C, Strnad P, European Alpha1-Liver Study Group. Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167 [Abstract] [Full Text] [Related]
11. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. Borel F, Tang Q, Gernoux G, Greer C, Wang Z, Barzel A, Kay MA, Shultz LD, Greiner DL, Flotte TR, Brehm MA, Mueller C. Mol Ther; 2017 Nov 01; 25(11):2477-2489. PubMed ID: 29032169 [Abstract] [Full Text] [Related]
14. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z. Rudnick DA, Huang J, Hidvegi T, Chu AS, Hale P, Munanairi A, Dietzen DJ, Cliften PF, Tycksen E, Lutkewitte AJ, Finck BN, Pak SC, Silverman GA, Perlmutter DH. Gastroenterology; 2022 Jul 01; 163(1):270-284. PubMed ID: 35301011 [Abstract] [Full Text] [Related]
16. FBG1 Is the Final Arbitrator of A1AT-Z Degradation. Wen JH, Wen H, Gibson-Corley KN, Glenn KA. PLoS One; 2015 Apr 01; 10(8):e0135591. PubMed ID: 26295339 [Abstract] [Full Text] [Related]
17. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, Maurice N, Mukherjee A, Goldbach C, Watkins S, Michalopoulos G, Perlmutter DH. Science; 2010 Jul 09; 329(5988):229-32. PubMed ID: 20522742 [Abstract] [Full Text] [Related]